Assessing the Bioavailability of Leading Phytonutrient Products

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05349032

Enrollment

Registered

2022-04-27

Start date

2022-03-01

Completion date

2022-06-30

Last updated

2022-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation

Keywords

infalmmation, bioavailability

Brief summary

This study will primarily test various phytonutrient-based supplements to see which gets absorbed into the body the best. The study will secondarily look at inflammatory markers in the urine to determine any change.

Detailed description

This study will primarily test various phytonutrient-based supplements to see which gets absorbed into the body the best. 120 mg of curcumin from brands Meriva, CurcElite, Lonvida, UltraCur, NovaSol. The study will secondarily look at inflammatory markers in the urine to determine any change.

Interventions

DIETARY_SUPPLEMENTCurcumin

Oral supplement

Study design

Allocation

NON_RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

BASIC_SCIENCE

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

MALE

Age

21 Years to 49 Years

Healthy volunteers

Yes

Inclusion criteria

* Age and gender

Exclusion criteria

* Cannot take any phytonutrient or curcumin supplement five days prior to commencement.

Design outcomes

Primary

Measure	Time frame	Description
Bioavailability	0, 1, 2, 4, and 12 hours	Blood Plasma

Countries

United States

Contacts

Primary ContactDavid Roberts, MPH

research@epiceuticallabs.com810777687

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026